ignacio Munoz-Sanjuan

Overview

Ignacio Munoz-Sanjuan serves as Chief Executive Officer at Rumi Scientific [1][2]. Munoz-Sanjuan previously held the position of Chief Executive Officer at Cajal Therapeutics from October 2022 to January 2024 [3]. Prior to that role, Munoz-Sanjuan worked as Vice President Biology at CHDI Management, Inc. from December 2007 to September 2022 [4]. Earlier career positions included Senior Scientist at Amgen from May 2006 to September 2007 [5], Research Fellow at Merck from April 2003 to March 2006 [6], and Postdoctoral Fellowship at The Rockefeller University from January 2000 to April 2003 [7]. Munoz-Sanjuan holds a Doctor of Philosophy in Neurobiology and Neurosciences from The Johns Hopkins University, completed between August 1994 and December 1999 [8], and a Bachelor of Science in Bioscience and Biotechnology from Drexel University, completed between September 1990 and May 1994 [9].

Career history

1. Chief Executive OfficerpresentRumi Scientific
2. CTChief Executive OfficerOct 2022 to Jan 2024Cajal Therapeutics
3. CMVice President BiologyDec 2007 to Sep 2022CHDI Management, Inc.
4. Senior ScientistMay 2006 to Sep 2007Amgen
5. Research FellowApr 2003 to Mar 2006Merck
6. Postdoctoral FellowshipJan 2000 to Apr 2003The Rockefeller University

Education

1. Doctor of Philosophy - PhD, Neurobiology and NeurosciencesAug 1994 - Dec 1999The Johns Hopkins University
2. Bachelor of Science - BS, Bioscience and biotechnologySep 1990 - May 1994Drexel University